PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
253.0K views | +60 today
Follow

Roche prépare l'arrivée en France du premier capteur implantable pour la mesure du glucose en continu

From www.ticpharma.com

PARIS (TICpharma) - Roche Diabetes Care France (groupe Roche) prépare l'arrivée dans l'Hexagone du premier capteur implantable de mesure du glucose en continu (CGM), Eversense, pour les diabétiques traités par insuline, et annonce un essai clinique français pour septembre.


No comment yet.

La réputation des laboratoires pharmaceutiques en chute libre

From pharmanalyses.fr

Les associations de patients jugent sévèrement la réputation des industriels de la pharma. Selon, Patient View, qui effectue son enquête annuelle auprès de 1 463 groupes de patients dans 105 pays, …
No comment yet.

Strong Medicine: Where Big Pharma Is Placing Bets In #digitalhealth In One Timeline  #hcsmeu #hcsmeufr

From www.cbinsights.com

Merck's Global Health Innovation Fund is leading the pack with 24 digital health investments since 2009.
No comment yet.

Digital Innovation team at @Bayer Announces CloudAspirin Experiment

From medium.com

In a showcase event in the middle of the Pacific Ocean, Bayer’s Digital innovation team today demonstrated CloudAspirin. CloudAspirin is a service to 3-D print Aspirin in the cloud, and deliver to…
No comment yet.

Parcours shopper & Pharmacie d'officine en 2017

From www.slideshare.net

Transformation digitale de la pharmacie d'officine Avant, Pendant & Après la visite sur le point de vente
No comment yet.

Engaging patients online can improve chronic disease management

From www.digitalcommerce360.com

The majority of patients (91%) with a chronic health condition need more help managing their disease.

One in five patients feel anxious or frustrated dealing with their chronic disease. Nearly four out of ten patients with a chronic condition admit they are only somewhat knowledgeable about how to best manage their health. A majority of patients want additional support from their providers, and nine out of 10 of those who want help managing a chronic condition say assistance from their provider would make a difference in their overall state of health.

Those responses are from a survey of 502 patients conducted by West Corp. and released in February at HIMSS 2017 in Orlando, Fla.

These findings also signal a need for more patient engagement in chronic care, and point to opportunities for healthcare organizations and providers to achieve better clinical and financial outcomes.

Web-enabled technology such as automated surveys allow providers to routinely monitor chronic patients.
 
 

Tweet This

The emotional burden of chronic disease is challenging enough for patients. But in addition to the fear, anxiety and frustration chronic patients feel, many also say they lack the knowledge and confidence necessary to successfully manage their health.

ADVERTISEMENT
 

44% of patients surveyed are only somewhat confident, at best, they are effectively managing their condition, and over half (59%) of patients with a chronic illness believe they are not doing everything they should be doing to manage their condition. As a result, one in five (20%) chronic patients rate their ability to manage their condition as fair or poor at best.

A lot of patients simply do not have a good grasp on health metrics—meaning they either don’t know what their current health metrics are, or they do not know what they should be. 43% of patients are only somewhat confident they know their current numbers for things like blood pressure and cholesterol. What’s more, even when patients do know their numbers, it is not guaranteed that they understand what those numbers mean. To make sense of health metrics and chronic disease management, patients need support from their healthcare providers

One in five patients feel they need 24-hour disease management assistance. Traditionally, chronic care has been delivered during face-to-face doctor visits. However, this outdated approach to chronic care does not support patients when and where they need help. Providers can help patients do a better job of managing their health by supporting them not just during office visits, but also at home and in daily life – where patients desire more assistance, especially online.

According to the survey, at least 70% of patients with a chronic condition would like more resources or clarity on how to manage their disease. Close to a third of patients say a better understanding of how to change unhealthy behaviors (35%), a more individualized treatment plan (33%) or tips and tools for handling their condition (31%) would help them be more effective in their treatment.

Providers must seize engagement opportunities

ADVERTISEMENT
 

There are many different ways providers can engage patients and support them between visits. As the West survey findings show, patients desire personalized and targeted communications and information, and they also want regular check-ins from providers. Three-quarters (75%) of chronic patients want their healthcare provider to contact them regularly and alert them if anything looks wrong (only 30% of patients report receiving regular check-ins to review their progress).

Web-enabled technology such as automated surveys allow providers to routinely monitor chronic patients, escalate cases where patients are at risk, and intervene before patients reach the point of needing acute care. According to the survey, there is untapped potential for using patient surveys. Just 5% percent of providers say they use survey check-ins that ask patients for feedback about treatment plans.

Biometric monitoring devices like heart rate monitors and blood pressure cuffs offer similar benefits as patient surveys. When asked to choose between a one-way and two-way monitoring device, more patients (53%) prefer a two-way device. These tools provide additional opportunities to engage and monitor patients at home, and could be leveraged more by providers.

CMS penalties and incentives

Potentially avoidable readmissions are costing hospitals $528 million in Medicare penalties for the 2017 fiscal year. Healthcare organizations know that reducing preventable readmissions is in their best interest financially, but many do not realize that they are missing opportunities to prevent readmissions by proactively engaging chronic patients.

ADVERTISEMENT
 

In January 2015, the Centers for Medicare & Medicaid Services began reimbursing chronic care management (CCM) services for qualified Medicare beneficiaries who have at least two chronic conditions expected to last longer than a year. CPT code 99490 reimbursement varies from state to state, but generally CMS reimburses at approximately $42.60 per beneficiary (every month) to physicians for implementing processes to manage patients outside of the clinical setting.

With government incentivizing chronic care management, and patients demanding it, providers can more successfully manage chronic diseases by more effectively engaging and supporting chronic patients.

Fonda Narke is director of product integration, West Corp. Healthcare Practice

No comment yet.

Clinicians are people, Platforms inspired by consumers; built for pharma

From worldofdtcmarketing.com

Clinicians are people – just like us. Like us, most of them are busy, have friends and start their day on social media. In just the last two years, our media habits changed dramatically and there a…
No comment yet.

Social Media in Pharma

From www.slideshare.net

Despite the fact that social media has had a significant impact on the way that people communicate with each other and has been adopted globally by every kind …
No comment yet.

Time to engage: How digital expands the appeal of patient engagement for pharma

From deep-dive.pharmaphorum.com

Adherence and outcome support commercially viable for pharma and primary care, suggests app developer Sebastian Gaede.
loicpharma's curator insight, April 18, 6:51 AM
Time to engage: How digital expands the appeal of patient engagement for pharma

Les défis du community management dans les laboratoires pharmaceutiques

From www.ticpharma.com

Le community manager de Leo Pharma, Wandrille de Préville, et le responsable de la communication digitale d'Abbvie, Emeric Pagès, ont expliqué comment leurs structures assurent leur présence sur les réseaux sociaux et s'adaptent à ces nouveaux médias dans un contexte réglementaire contraint. ”
Denise Silber's curator insight, March 23, 1:17 PM
Vaste sujet ! Jusqu'ici, les laboratoires n'ont pas été trop  impactés par les exemples plus libéraux de leurs confrères. Affaire à suivre.

Why Social Media Should Matter to Pharma Marketers

From www.scoop.it

loicpharma's curator insight, April 18, 6:21 AM
L'importance des médias sociaux chez les responsables marketing dans l'industrie pharmaceutique

Digitalisation de la supply chain, mais de quoi parlons nous ?

From logistique-pour-tous.fr

Digitalisation, digitalisation.... ce terme revient régulièrement en ce moment. Comment se traduit celle-ci dans le monde de la supply chain ?
No comment yet.

How Does Pharma Learn To Speak “Patient”? -Inspire

From corp.inspire.com

This blog presents the e-Book "How Does Pharma Learn to Speak "Patient"? a discourse analysis of patient communication teaching readers to speak patient.
No comment yet.

Big Pharma finds a hit with disease awareness social media posts in 2016

From novamedica.com

Pharma marketers continued to up their social media game in 2016, according to a new report, with many embracing disease awareness and charitable causes to drive engagement across social networks.

Unmetric, a social media market intelligence company, analyzed the U.S. activity and consumer engagement of 15 big pharma brands in 2016, and it found that disease awareness was the most engaging topic across all social media and pharma companies. Specifically on Facebook, company news and milestones also captured consumer attention, while on Twitter and LinkedIn, charitable causes and health tips scored well with consumers.

“When we looked at all the campaigns, content and hashtags that worked, the broad finding that came out was that all pharma companies saw the highest engagement when talking about the things that matter to their customers—most importantly the disease or condition they’re dealing with,” Lakshmanan Narayan, co-founder and CEO at Unmetric, said in an interview. “The maximum engagement came when they demonstrated empathy for what their customer and community is going through.”

Using a weighted scoring system of likes, comments and shares to gauge engagement, Unmetric found some of the most engaging Facebook posts in 2016 were Eli Lilly's posts about its online program to save money on its insulin products; Novo Nordisk's information about the carbon footprint of diabetes products; Boehringer Ingelheim's efforts for Brain Awareness Week; and Bayer’s 360-degree view of its illuminated brand cross from its rooftop.

On Twitter, Bayer’s announcement of its Monsanto acquisition intent scored high, while a Novo Nordisk post welcoming hundreds of new employees ranked high on LinkedIn.

But while pharma has made social media strides, not every pharma brand has company accounts on all social media, according to Unmetric. All 15 brands it studied are on Twitter and 11 maintain corporate Facebook pages, but only three companies—Bayer, Boehringer Ingelheim and Eli Lilly—have Instagram accounts.

Unmetric also tracks other metrics, such as number and types of posts, reach, impressions, and customer reply time on social media. When looking at hashtags, for instance, on Facebook, campaigns like Boehringer Ingelheim’s #HiddenHeartChallenge and Eli Lilly’s #EndALZ scored high, while #WeCanICan from Bristol-Myers Squibb and #CervicalHealthMonth from Merck also did well.

“Three or four years ago, when we talked to a pharma company, they would be relatively reluctant to get onto social networks because of all the regulations,” Narayan said. “It’s interesting to see how far we’ve come since then with what brands now say and do on social networks, and in general, brands speaking for a cause is really what strikes a chord the most.”

Source

 
No comment yet.

KPMG Releases Global Technology Innovation Report #hcsmeufr

From www.crowdfundinsider.com

  KMPG just released part one of its Changing Landscape of Disruptive Technologies 2017 publication series, Global Technology Innovation Hubs. In the
No comment yet.

Why pharma companies and digital healthcare startups should embrace 

From medtechengine.com

Operating extensively within the digital healthcare industry, both as a startup, as well as a digital marketing agency supporting global pharmaceutical companies has taught us that both have a need that the other can readily offer.

As pharma and consumer healthcare companies are quickly realising, the future of healthcare lies in the technologies of tomorrow. For digital healthcare startups on the other hand, the opportunities to see their dreams realised have never been more exciting. So, how and why can both the pharma company and the startup make positive headway here.

No comment yet.

Mobile Trends in Pharma & Healthcare Advertising #hcsmeufr

From www.slideshare.net

Seventy percent of Internet use is now on mobile — and taking market share from other platforms. Adapted from a live presentation from Google NY’s Mobile Trend…
No comment yet.

John Flannery : « Toute l'industrie de la santé va devenir digitale » 

From www.lesechos.fr

John Flannery dirige l'activité santé de General Electric. Un pôle qui emploie environ 5.000 ingénieurs logiciel. Il livre sa vision du virage numérique dans le domaine de la santé.

Sébastien Deréson's curator insight, April 9, 8:08 AM
John Flannery : « Toute l'industrie de la santé va devenir digitale »  | @scoopit via @Christelle77ESP http://sco.lt/...

The 3-way partnership that is transforming Digital Pharma #hcsmeufr #esante

From www.youtube.com

Pharma enterprises have a uniquely complex set of challenges when it comes to launching products in the digital space. As their digital partner, customer
No comment yet.

Understanding the Consumer Journey in Pharma Marketing Today-Bryan Cohen, Digital Platform Lead, Promotional Operations, Pfizer

From www.slideshare.net

Ahead of the marcus evans PharmaMarketing Summit 2017, Bryan Cohen discusses why pharma marketers need to view the journey through the consumer’s eyes
No comment yet.

JIM.fr - Promotion des médicaments : la HAS renforce les règles

From www.jim.fr

Paris, le jeudi 6 avril 2017 - Depuis décembre 2004, la promotion de médicaments auprès des professionnels de santé déployée par les laboratoires pharmaceutiques, autrement appelée « visite médicale », doit être certifiée conformément à un référentiel de la Haute autorité de santé (HAS). Cette charte de qualité signée entre les pouvoirs publics et les industriels définit notamment les principes à respecter en termes d'information délivrée aux professionnels de santé, de déontologie [...]
No comment yet.

Sanofi gets FDA clearance for insulin dose calculator app

From www.mobihealthnews.com

Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared at the end of March, is called My Dose Coach.
No comment yet.

Pharma Video Just Got Huge

From notesfromarepsjournal.com

For what feels like a long time now, I have been talking with photographers about the value clients are placing on video.  I have been encouraging photographers to find a solution for motion that works for them, whether it be a DP or they themselves holding the camera.  Either way, the writing has been on…
No comment yet.

Six Success Imperatives For Building A World-Class Digital Factory In Pharma

From dt-associates.com

Digital factories—central, shared organizations that coordinate and deliver digital platforms and related services for the wider company—are here to stay. But are large pharmaceutical firms getting the most out of them? And how do you set the team up for success? Digital executives at global pharmaceutical firms need to calibrate six success factors to achieve the promised benefits of digital factories: a competitive time to market, reduced cost, and world-class digital capability.
No comment yet.